UAB Mogemas, working with ProBaltic Consulting, won three life sciences R&D projects totalling €158,060 under the Idėja LT and Intelektas LT+ measures — spanning a functional beverage with amino acids, food supplements, and a medicinal preparation for treating iron-deficiency anaemia.
The challenge
Mogemas operates at the intersection of food and pharma, with two product tracks — a functional beverage and an anaemia treatment preparation derived from animal blood. Both required scientific validation and R&D financing well before commercialisation, and each sat at a different stage of technological maturity.
What we did
ProBaltic Consulting designed a staged funding sequence instead of a single application: a feasibility assessment under Idėja LT first, followed by full R&D projects for both product lines under Intelektas LT+. We prepared the R&D applications and administered the projects.
Why staging works in life sciences
Life sciences R&D carries long timelines and high evidential requirements. The Idėja LT feasibility stage de-risked the science and produced exactly the evidence the subsequent full applications needed — turning one uncertain big bet into three fundable, sequenced projects. This measure-chaining pattern (feasibility → full R&D) remains one of the most reliable strategies for research-intensive SMEs in Lithuania.
The result
Three funded projects across the company’s portfolio: feasibility and R&D for the functional beverage, and development of the food supplements and medicinal preparation targeting iron-deficiency anaemia — €158K of non-dilutive financing carrying the products toward market readiness.
Planning a similar project? We assess eligibility free of charge within 1–2 business days, and our fee applies only to funding you win. See the current major EU funding calls in Lithuania or contact us.